南美和中美洲瞬时蛋白表达市场预测至 2031 年 - 区域分析 - 按产品类型(仪器、试剂、表达载体和感受态细胞)、应用(基因组研究、基因治疗、生物生产、癌症研究和药物开发)和最终用户(制药和生物技术公司、学术和研究机构以及临床研究组织)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 140    |    Report Code: TIPRE00022180    |    Category: Life Sciences

South & Central America Transient Protein Expression Market
2023 年,南美和中美洲瞬时蛋白表达市场价值为 4370 万美元,预计到 2031 年将达到 6423 万美元;预计 2023 年至 2031 年的复合年增长率为 4.9%。

蛋白质表达系统的应用日益广泛,推动南美和中美洲瞬时蛋白表达市场发展

基于动物和植物细胞的瞬时蛋白表达系统已经使用了三十年。近年来,蛋白质组学的重大进步导致了更新的重组蛋白品种的出现。瞬时蛋白表达在动物和植物细胞中的实用性和可重复性鼓励研发活动将其应用扩展到人类细胞系中。许多合同研发组织以及生物制药公司等都致力于将瞬时蛋白表达纳入其生产流程。这种表达系统允许他们使用不同的基因来创建重组蛋白,而不依赖于稳定细胞系的开发。

临时蛋白表达工艺广泛应用于生长因子、细胞因子、激素、血液制品、改性人类蛋白和单克隆抗体的制造。此外,创建和使用有效的生物加工技术对于具有重要治疗价值的重组蛋白的商业合成至关重要。生物加工领域的最新发展正在被应用于提供产生重组蛋白的有效方法。现代质量源于设计概念、连续上游加工、连续色谱、集成连续生物加工、用于高效生物过程优化的高通量设备、一次性系统和用于更高产量高质量产品的过程分析技术是最近的发展。

自 COVID-19 大流行开始以来,瞬时蛋白表达平台越来越多地用于疫苗开发应用。各种研究人员开始使用瞬时蛋白表达系统广泛研究 SARS-CoV-2 及其变体。例如,2020 年 3 月至 4 月,Absolute Antibody (UK) 扩大了多克数量级的不同抗 SARS-CoV-2 刺突蛋白的生产,以帮助开发中和抗体。同样,瞬时蛋白表达系统被广泛用于生产阳性对照蛋白,作为体外诊断试剂盒开发过程的一部分。因此,蛋白质表达系统的应用日益广泛,推动了瞬时蛋白表达市场的增长。

南美和中美瞬时蛋白表达市场概览

南美和中美瞬时蛋白表达市场细分为阿根廷、巴西和南美和中美其他地区。巴西预计将占据该地区的主要市场份额。由于医疗设施的扩大、遗传疾病患病率的上升以及精准医疗在该地区的日益普及,该地区的瞬时蛋白表达市场预计将快速增长。

南美和中美瞬时蛋白表达市场收入及预测至 2031 年(百万美元)

南美和中美瞬时蛋白表达市场细分

南美和中美瞬时蛋白表达市场分为产品类型、应用、最终用户和国家。

根据产品类型,南美和中美瞬时蛋白表达市场细分为仪器、试剂、表达载体和感受态细胞。仪器部分在 2023 年占据最大市场份额。

在应用方面,南美和中美瞬时蛋白表达市场细分为基因组研究、基因治疗、生物生产、癌症研究和药物开发。基因组研究部分在 2023 年占据最大市场份额。

根据最终用户,南美和中美瞬时蛋白表达市场细分为制药和生物技术公司、学术和研究机构以及临床研究组织。 2023 年,制药和生物技术公司部门占据了最大的市场份额。

按国家/地区划分,南美和中美瞬时蛋白表达市场分为巴西、阿根廷和南美和中美其他地区。2023 年,巴西占据了南美和中美瞬时蛋白表达市场份额的主导地位。

Thermo Fisher Scientific Inc、Merck KGaA、QIAGEN NV、GenScript Biotech Corporation、Promega Corp、Takara Bio Inc、New England Biolabs、Agilent Technologies Inc、Mirus Bio LLC、Bio-Rad Laboratories Inc、Lonza Group AG 和 MaxCyte Inc 是南美和中美瞬时蛋白表达市场的一些领先公司。

South & Central America Transient Protein Expression Strategic Insights

Strategic insights for South & Central America Transient Protein Expression involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-transient-protein-expression-market-strategic-framework.webp
Get more information on this report

South & Central America Transient Protein Expression Report Scope

Report Attribute Details
Market size in 2019 US$ 40.3 Million
Market Size by 2027 US$ 56.1 Million
Global CAGR (2020 - 2027) 4.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品类型
  • 仪器
  • 试剂
  • 表达载体
  • 感受态细胞
By 应用
  • 基因组研究
  • 基因治疗
  • 生物生产
  • 癌症研究
  • 药物开发
By 最终用户
  • 制药和生物技术公司
  • 学术和研究机构
  • 临床研究组织
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • QIAGEN
  • GenScript
  • Promega Corporation
  • Takara Bio Inc.
  • MERIDIAN BIOSCIENCE, INC.
  • New England Biolabs
  • Mirus Bio LLC
  • Agilent Technologies, Inc.
  • Get more information on this report

    South & Central America Transient Protein Expression Regional Insights

    The regional scope of South & Central America Transient Protein Expression refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-transient-protein-expression-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Transient Protein Expression Market

    • Thermo Fisher Scientific Inc     
    • Merck KGaA                                      
    • QIAGEN NV                                          
    • GenScript Biotech Corporation     
    • Promega Corp                                     
    • Takara Bio Inc                                     
    • New England Biolabs             
    • Agilent Technologies Inc         
    • Mirus Bio LLC                                
    • Bio-Rad Laboratories Inc          
    • Lonza Group AG
    • MaxCyte Inc                                       
    Frequently Asked Questions
    How big is the South & Central America Transient Protein Expression Market?

    The South & Central America Transient Protein Expression Market is valued at US$ 40.3 Million in 2019, it is projected to reach US$ 56.1 Million by 2027.

    What is the CAGR for South & Central America Transient Protein Expression Market by (2020 - 2027)?

    As per our report South & Central America Transient Protein Expression Market, the market size is valued at US$ 40.3 Million in 2019, projecting it to reach US$ 56.1 Million by 2027. This translates to a CAGR of approximately 4.4% during the forecast period.

    What segments are covered in this report?

    The South & Central America Transient Protein Expression Market report typically cover these key segments-

  • 产品类型 (仪器, 试剂, 表达载体, 感受态细胞)
  • 应用 (基因组研究, 基因治疗, 生物生产, 癌症研究, 药物开发)
  • 最终用户 (制药和生物技术公司, 学术和研究机构, 临床研究组织)
  • What is the historic period, base year, and forecast period taken for South & Central America Transient Protein Expression Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Transient Protein Expression Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South & Central America Transient Protein Expression Market?

    The South & Central America Transient Protein Expression Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • QIAGEN
  • GenScript
  • Promega Corporation
  • Takara Bio Inc.
  • MERIDIAN BIOSCIENCE, INC.
  • New England Biolabs
  • Mirus Bio LLC
  • Agilent Technologies, Inc.
  • Who should buy this report?

    The South & Central America Transient Protein Expression Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Transient Protein Expression Market value chain can benefit from the information contained in a comprehensive market report.